Recruiting

Preemptive AnalgesiaManagement of Postoperative Pain With Preemptive Analgesia in Cesarean Section

Sponsor:

Mark Kosanovich

Code:

NCT02879435

Conditions

Labor Pain

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Accepted

Interventions

Bupivacaine

Placebo

Study Details

Brief summary:

This research will explore the question of whether preincisional skin infiltration with bupivacaine 0.25% decreases postoperative pain after Cesarean delivery.

Conditions

Labor Pain

Study ID

NCT02879435

Start date

Jun, 2016

Status verified date

Aug, 2016

Completion date

Mar, 2017

Anticipated

Primary completion date

Dec, 2016

Anticipated

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Accepted

Inclusion Criteria:

adult pregnant women to age 45 with scheduled cesarean sections at Mercy Hospital and Medical Center

Exclusion Criteria:

Emergent cesarean sections and subjects with contraindications to bupivacaine

Study Design

Enrollment

120 participants

Anticipated

Allocation

Randomized

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: bupivacaine

Intervention

placebo comparator: Placebo

Control

Interventions

Bupivacaine

pre-operative wound infiltration with 10 ml of numbing medicine

Placebo

pre-operative wound infiltration with 10 ml of sterile water

Primary outcome measure

Final score on the visual analogous scale [ Time Frame: 120 minutes after arrival in the recovery room ]

Central Contacts and Locations

Central contacts

Kathy Tom, DO

4158286323 kptom168@gmail.com

Mark Kosanovich, MD

3125672402 mekosanovich@yahoo.com

Locations

Mercy Hospital & Medical Center

Recruiting

Chicago, Illinois, United States, 60616

Contacts

Michael Kuby

312-567-8795 michael.kuby@mercy-chicago.org

Principal Investigator:

Mark Kosanovich, MD

More Information

Sponsor

Mark Kosanovich

Last update posted

Aug 25, 2016

Last verified

Aug, 2016

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Mark Kosanovich on 2016-08-25.